-
Markten
-
Aandelen
Sustainable finance2025 Euronext ESG Trends ReportLees meerA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeLees meerInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondsen
-
Obligaties
European Defence BondsGroupe BPCE lists the first bondLees meerFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Gestructureerde producten
-
Derivaten
Where European Government Bonds Meet the FutureFixed Income derivativesLees meerTrade mini bond futures on main European government bonds
-
Commodities
- Overzicht
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Levering en afwikkeling
- Specificaties en regelingen
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLees meerEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Meer
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLees meerJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 05 Nov 2025 18:00 CET |
EQUASENS | EQUASENS : Chiffre d'affaires au 30 septembre 2025 | 20101025 Health Services | Sales |
| 05 Nov 2025 18:00 CET |
EQUASENS | Equasens: Q3 2025 revenue | 20101025 Health Services | Sales |
| 30 Sep 2025 18:04 CEST |
EQUASENS | EQUASENS : Mise à disposition du rapport financier semestriel 2025 | 20101025 Health Services | Income |
| 29 Sep 2025 08:00 CEST |
EQUASENS | EQUASENS : Bilan S1 2025 contrat de liquidité | 20101025 Health Services | Other subject |
| 26 Sep 2025 18:00 CEST |
EQUASENS | EQUASENS : Résultats semestriels 2025 | 20101025 Health Services | Income |
| 26 Sep 2025 18:00 CEST |
EQUASENS | Equasens: 2025 half-year results | 20101025 Health Services | Income |
| 31 Jul 2025 18:00 CEST |
EQUASENS | EQUASENS : Chiffre d’affaires au 30 juin 2025 à 116,0 M€ | 10101015 Software | Sales |
| 31 Jul 2025 18:00 CEST |
EQUASENS | Equasens: H1 revenue at 30 June 2025: €116.0m | 10101015 Software | Sales |
| 03 Jul 2025 18:00 CEST |
EQUASENS | EQUASENS : Nomination à la direction de la Division Pharmagest | 10101015 Software | Journal / appointments |
| 03 Jul 2025 18:00 CEST |
EQUASENS | Equasens: Appointment at the head of the Pharmagest Division | 10101015 Software | Journal / appointments |
| 01 Jul 2025 19:00 CEST |
EQUASENS | EQUASENS : Assemblée Générale - Résultats des votes | 10101015 Software | General meeting / Board Meeting |
| 01 Jul 2025 19:00 CEST |
EQUASENS | Equasens: General meeting - Results of the votes | 10101015 Software | General meeting / Board Meeting |
| 30 Jun 2025 18:00 CEST |
EQUASENS | EQUASENS : ACQUISITION DES ACTIVITES DIS ET RESURGENCES | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 30 Jun 2025 18:00 CEST |
EQUASENS | Equasens: acquisition of DIS and RESURGENCES BUSINESSES | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 06 Jun 2025 18:00 CEST |
EQUASENS | EQUASENS : modalités de mise à disposition des documents préparatoires à l'AG | 10101015 Software | General meeting / Board Meeting |
| 06 Jun 2025 18:00 CEST |
EQUASENS | Equasens: availability of AGM preparatory materials | 10101015 Software | General meeting / Board Meeting |
| 12 May 2025 18:00 CEST |
EQUASENS | EQUASENS : Chiffre d’affaires au 31 mars 2025 | 10101015 Software | Sales |
| 12 May 2025 18:00 CEST |
EQUASENS | Equasens: Q1 revenue at 31 March 2025 | 10101015 Software | Sales |
| 30 Apr 2025 16:00 CEST |
EQUASENS | EQUASENS : | 10101015 Software | Income |
| 30 Apr 2025 08:00 CEST |
EQUASENS | EQUASENS : ENTREE EN NEGOCIATION EXCLUSIVE AVEC UN EDITEUR DE SOLUTIONS LOGICIELLES FRANÇAIS | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 30 Apr 2025 08:00 CEST |
EQUASENS | Equasens: EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 28 Mar 2025 18:00 CET |
EQUASENS | EQUASENS : Résultats annuels 2024 | 10101015 Software | Income |
| 28 Mar 2025 18:00 CET |
EQUASENS | Equasens: 2024 annual results | 10101015 Software | Income |
| 06 Feb 2025 18:00 CET |
EQUASENS | EQUASENS : Chiffre d’affaires au 31 décembre 2024 | 10101015 Software | Sales |
| 06 Feb 2025 18:00 CET |
EQUASENS | Equasens: 2024 annual revenue | 10101015 Software | Sales |
| 08 Jan 2025 18:00 CET |
EQUASENS | EQUASENS : bilan semestriel S2 2024 du contrat de liquidité contracté avec Gilbert Dupont | 10101015 Software | Share history |
| 27 Dec 2024 18:00 CET |
EQUASENS | Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 27 Dec 2024 18:00 CET |
EQUASENS | EQUASENS : acquisition stratégique de Calimed, expert en logiciel SaaS pour les médecins libéraux et les chirurgiens | 10101015 Software | Mergers, Acquiqitions, Transferts |
| 21 Nov 2024 18:00 CET |
EQUASENS | EQUASENS : Digipharmacie obtient l’immatriculation officielle en tant que Plateforme de Dématérialisation Partenaire (PDP) | 10101015 Software | Corporate life |
| 20 Nov 2024 18:01 CET |
EQUASENS | EQUASENS : Intelligence artificielle : Equasens et Posos transforment la dispensation pharmaceutique | 10101015 Software | Corporate life |
| 07 Nov 2024 18:00 CET |
EQUASENS | EQUASENS : Chiffre d’affaires au 30 septembre 2024 à 158,2 M€ - Retour de la croissance sur le T3 (+0,3%) | 10101015 Software | Sales |
| 07 Nov 2024 18:00 CET |
EQUASENS | Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%) | 10101015 Software | Sales |
| 30 Sep 2024 20:04 CEST |
EQUASENS | EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2024 | 10101015 Software | Income |
| 27 Sep 2024 18:00 CEST |
EQUASENS | EQUASENS : Résultats semestriels 2024 | 10101015 Software | Income |
| 27 Sep 2024 18:00 CEST |
EQUASENS | Equasens: 2024 half-year results | 10101015 Software | Income |
| 02 Aug 2024 18:00 CEST |
EQUASENS | EQUASENS : Chiffre d’affaires S1 2024 | 10101015 Software | Sales |
| 02 Aug 2024 18:00 CEST |
EQUASENS | Equasens: H1 2024 revenue | 10101015 Software | Sales |
| 05 Jul 2024 18:30 CEST |
EQUASENS | EQUASENS : BILAN SEMESTRIEL S1-2024 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT | 10101015 Software | Share history |
| 05 Jul 2024 18:00 CEST |
EQUASENS | EQUASENS : AGO du 27 juin 2024 - RESULTAT DU VOTE DES RESOLUTIONS | 10101015 Software | General meeting / Board Meeting |
| 05 Jul 2024 18:00 CEST |
EQUASENS | Equasens: RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024 | 10101015 Software | General meeting / Board Meeting |
| 10 Jun 2024 18:00 CEST |
EQUASENS | EQUASENS : ASSEMBLEE GENERALE ORDINAIRE ANNUELLE - AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES | 10101015 Software | General meeting / Board Meeting |
| 10 Jun 2024 18:00 CEST |
EQUASENS | Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS | 10101015 Software | General meeting / Board Meeting |
| 07 May 2024 18:00 CEST |
EQUASENS | EQUASENS : Chiffre d’affaires T1 2024 | 10101015 Software | Sales |
| 07 May 2024 18:00 CEST |
EQUASENS | Equasens: Q1 2024 revenue | 10101015 Software | Sales |
| 30 Apr 2024 18:45 CEST |
EQUASENS | EQUASENS : Modalités de mise à disposition de l'URD 2023 | 10101015 Software | Income |
| 29 Mar 2024 18:02 CET |
EQUASENS | EQUASENS : Résultats Annuels 2023 | 10101015 Software | Income |
| 29 Mar 2024 18:02 CET |
EQUASENS | Equasens: 2023 Annual Results | 10101015 Software | Income |
| 07 Feb 2024 18:30 CET |
EQUASENS | EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE | 10101015 Software | Other subject |
| 06 Feb 2024 18:00 CET |
EQUASENS | EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€ | 10101015 Software | Sales |
| 06 Feb 2024 18:00 CET |
EQUASENS | Equasens: 2023 revenue: €219.7m, +2.6% | 10101015 Software | Sales |